A new study focusing on the common CA-125 blood test found that some populations didn’t show elevated markers at diagnosis ...

Since the FDA approval of CA-125 as a tumor marker test, when a pelvic mass could ... Distinguishing between PID, genital TB, and ovarian cancer is extremely difficult given the clinical features ...

CA-125, a protein produced by ovarian cancer cells and detectable through a blood test, became the first FDA-approved biomarker for cancer diagnosis and surveillance in 1981. Its discovery marked ...

The researchers analyzed data from more than 200,000 women with ovarian cancer from 2004 through 2020 who'd had a CA-125 blood test. Black and Native American patients were 23 percent less likely ...

The measurement of serum CA-125 antigen is a standard procedure in the management of patients with advanced ovarian cancer. A study by Markman et al. showed that decreased concentration of serum ...

Data were analyzed from 76 women who had previously undergone surgery or chemotherapy for primary or recurrent epithelial ovarian cancer ... the two tests (P>0.05). Serum CA-125 values, however ...

To gauge your odds of ovarian cancer, doctors run a test of your blood -- or sometimes saliva -- called the BRCA gene test. The CA-125 test looks for certain proteins in your blood. Ovarian cancer ...

Current methods of diagnosis and screening, like Pap smears, CA-125 tests and ultrasound, are also poor at correctly identifying early-stage ovarian cancer. Developed by researchers at the Brigham ...

which suggested in 2020 the combination with paclitaxel had a 58% or higher objective response rate using the CA-125 ovarian cancer scale than paclitaxel alone. Since then, VBL has also opted to ...

An Aiims study suggests lymph node removal after chemotherapy may improve survival in advanced ovarian cancer patients, ...

One of the two most common ways to test for ovarian cancer is to check for elevated levels of a protein called CA-125 in the patient’s blood, according to the American Cancer Society.

Caution must be used when screening women with suspected ovarian cancer for CA-125 levels. Additional diagnostic procedures are needed to differentiate ovarian cancer from PID and other causes of ...